Cargando…
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357589/ https://www.ncbi.nlm.nih.gov/pubmed/37474972 http://dx.doi.org/10.1186/s12943-023-01821-y |
| _version_ | 1785075524161241088 |
|---|---|
| author | Xu, Juan Shao, Tingting Song, Mingxu Xie, Yunjin Zhou, Jialiang Yin, Jiaqi Ding, Na Zou, Haozhe Li, Yongsheng Zhang, Jiwei |
| author_facet | Xu, Juan Shao, Tingting Song, Mingxu Xie, Yunjin Zhou, Jialiang Yin, Jiaqi Ding, Na Zou, Haozhe Li, Yongsheng Zhang, Jiwei |
| author_sort | Xu, Juan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10357589 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103575892023-07-21 Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer Xu, Juan Shao, Tingting Song, Mingxu Xie, Yunjin Zhou, Jialiang Yin, Jiaqi Ding, Na Zou, Haozhe Li, Yongsheng Zhang, Jiwei Mol Cancer Correction BioMed Central 2023-07-20 /pmc/articles/PMC10357589/ /pubmed/37474972 http://dx.doi.org/10.1186/s12943-023-01821-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Xu, Juan Shao, Tingting Song, Mingxu Xie, Yunjin Zhou, Jialiang Yin, Jiaqi Ding, Na Zou, Haozhe Li, Yongsheng Zhang, Jiwei Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title | Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title_full | Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title_fullStr | Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title_full_unstemmed | Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title_short | Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer |
| title_sort | correction: mir22hg acts as a tumor suppressor via tgfβ/smad signaling and facilitates immunotherapy in colorectal cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357589/ https://www.ncbi.nlm.nih.gov/pubmed/37474972 http://dx.doi.org/10.1186/s12943-023-01821-y |
| work_keys_str_mv | AT xujuan correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT shaotingting correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT songmingxu correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT xieyunjin correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT zhoujialiang correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT yinjiaqi correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT dingna correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT zouhaozhe correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT liyongsheng correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer AT zhangjiwei correctionmir22hgactsasatumorsuppressorviatgfbsmadsignalingandfacilitatesimmunotherapyincolorectalcancer |